Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China.
Acta Biochim Biophys Sin (Shanghai). 2023 Oct 25;55(10):1539-1550. doi: 10.3724/abbs.2023134.
CRISPR-based detection technologies have been widely explored for molecular diagnostics. However, the challenge lies in converting the signal of different biomolecules, such as nucleic acids, proteins, small molecules, exosomes, and ions, into a CRISPR-based nucleic acid detection signal. Understanding the detection of different biomolecules using CRISPR technology can aid in the development of practical and promising detection approaches. Unfortunately, existing reviews rarely provide an overview of CRISPR-based molecular diagnostics from the perspective of different biomolecules. Herein, we first introduce the principles and characteristics of various CRISPR nucleases for molecular diagnostics. Then, we focus on summarizing and evaluating the latest advancements in CRISPR-based detection of different biomolecules. Through a comparison of different methods of amplification and signal readout, we discuss how general detection methods can be integrated with CRISPR. Finally, we conclude by identifying opportunities for the improvement of CRISPR in quantitative, amplification-free, multiplex, all-in-one, and point-of-care testing (POCT) purposes.
基于 CRISPR 的检测技术已广泛应用于分子诊断领域。然而,挑战在于如何将不同生物分子(如核酸、蛋白质、小分子、外泌体和离子)的信号转化为基于 CRISPR 的核酸检测信号。了解 CRISPR 技术对不同生物分子的检测有助于开发实用且有前景的检测方法。遗憾的是,现有的综述很少从不同生物分子的角度全面介绍基于 CRISPR 的分子诊断。本文首先介绍了各种用于分子诊断的 CRISPR 核酸酶的原理和特点。然后,我们重点总结和评估了基于 CRISPR 的不同生物分子检测的最新进展。通过比较不同的扩增和信号读取方法,我们探讨了如何将一般的检测方法与 CRISPR 相结合。最后,我们确定了在定量、无扩增、多重、一体化和即时检测(POCT)方面改进 CRISPR 的机会。